Evidence map›Paper›PMID 35013703›Full record

ArticleSustainable cities and society2022

Adapting Urban Transport Planning to the COVID-19 Pandemic: An Integrated Fermatean Fuzzy Model.

Vladimir Simić, Ivan Ivanović, Vladimir Đorić, Ali Ebadi Torkayesh

Abstract read
In one paragraph

Article in Sustainable cities and society, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Vladimir SimićUniversity of Belgrade, Faculty of Transport and Traffic Engineering, Vojvode Stepe 305, 11010, Belgrade, Serbia.
Ivan IvanovićUniversity of Belgrade, Faculty of Transport and Traffic Engineering, Vojvode Stepe 305, 11010, Belgrade, Serbia.
Vladimir ĐorićUniversity of Belgrade, Faculty of Transport and Traffic Engineering, Vojvode Stepe 305, 11010, Belgrade, Serbia.
Ali Ebadi TorkayeshSchool of Business and Economics, RWTH Aachen University, 52072 Aachen, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The critical worldwide problem of adapting urban transport planning to COVID-19 is for the first time comprehensively addressed and solved in this study. It primarily aims to help transport planners increase the resilience of transport systems. Firstly, a multi-level decision-making hierarchy structure based on four main criteria and 17 sub-criteria is introduced for relevant stakeholders to provide a practical framework for assessing existing transport plans. Then, a three-stage integrated Fermatean fuzzy model for adapting urban transport planning to the pandemic is presented. The model hybridizes the method based on the removal effects of criteria (MEREC) and combined compromise solution (CoCoSo) method into a unique methodological framework under the Fermatean fuzzy environment. A case study provides decision-making guidelines on how to adapt transport plans to COVID-19 in the real-world context of Belgrade, Serbia. The research findings show that the pandemic significantly changed the priorities of transport planning strategies and measures. "Non-motorized travel" is now the best alternative since its numerous short-term measures lead to better transport service. The major advantages of the introduced model are higher flexibility and a more precise fusion of experts' preference information. The integrated Fermatean fuzzy model could be used for adapting other emerging problems to COVID-19.

Indexed as

CoCoSoCOVID-19Fermatean Fuzzy SetMulti-Criteria Decision-MakingSustainabilityTransport Planning

Identifiers

PMID35013703
PMCPMC8733251

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.